UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

Hall, S; Surova, Y; Ohrfelt, A; Blennow, K; Zetterberg, H; Hansson, O; (2016) Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease. Movement Disorders , 31 (6) pp. 898-905. 10.1002/mds.26578. Green open access

[img]
Preview
Text
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.pdf - Published version

Download (422kB) | Preview

Abstract

Objective: The purpose of this study was to investigate whether cerebrospinal fluid (CSF) levels of tau, phosphorylated tau, β‐amyloid42, α‐synuclein, neurofilament light, and YKL‐40 change over time and if changes correlate with motor progression and/or cognitive decline in patients with PD and controls. / Methods: We included 63 patients with PD (nondemented) and 21 neurologically healthy controls from the prospective and longitudinal Swedish BioFINDER study, all of whom had clinical assessments and lumbar punctures at baseline and after 2 years. / Results: CSF tau levels correlated strongly with α‐synuclein. The levels of CSF α‐synuclein, tau, phosphorylated tau, neurofilament light, and YKL‐40, but not β‐amyloid42, increased in CSF over 2 years in PD. No changes were seen in the control group. Studying patients with a short disease duration ( ≤ 5 years) and patients with a long disease duration ( > 5 years) separately, α‐synuclein and tau only increased in the PD group with long disease duration. In the PD group, an increase in phosphorylated tau over 2 years correlated with faster motor progression and faster cognitive decline. An increase in YKL‐40 over 2 years correlated with faster cognitive decline. / Conclusion: CSF biomarkers reflecting Lewy body pathology and neurodegeneration (α‐synuclein), neuronal degeneration (tau, phosphorylated tau, and neurofilament light), and inflammation (YKL‐40) increase significantly over 2 years in PD. CSF levels of α‐synuclein and tau correlate and remain stable in the early symptomatic phase of PD but increase in the later phase. We hypothesize that CSF α‐synuclein levels might increase as a result of more intense neurodegeneration in PD with long disease duration.

Type: Article
Title: Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
Location: Assisi, ITALY
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/mds.26578
Publisher version: https://doi.org/10.1002/mds.26578
Language: English
Additional information: Copyright © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Parkinson's disease, cerebrospinal fluid, longitudinal, biomarkers, prognosis
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10073548
Downloads since deposit
41Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item